HomeCompareRPFG vs PFE

RPFG vs PFE: Dividend Comparison 2026

RPFG yields 125000.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RPFG wins by $1019369930368.56M in total portfolio value
10 years
RPFG
RPFG
● Live price
125000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1019369930368.61M
Annual income
$390,340,295,156,222,850.00
Full RPFG calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — RPFG vs PFE

📍 RPFG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPFGPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPFG + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RPFG pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPFG
Annual income on $10K today (after 15% tax)
$10,625,000.00/yr
After 10yr DRIP, annual income (after tax)
$331,789,250,882,789,440.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, RPFG beats the other by $331,789,250,882,767,100.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPFG + PFE for your $10,000?

RPFG: 50%PFE: 50%
100% PFE50/50100% RPFG
Portfolio after 10yr
$509684965184.33M
Annual income
$195,170,147,578,124,540.00/yr
Blended yield
38.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

RPFG
No analyst data
Altman Z
-0.8
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPFG buys
0
PFE buys
0
No recent congressional trades found for RPFG or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPFGPFE
Forward yield125000.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$1019369930368.61M$49.6K
Annual income after 10y$390,340,295,156,222,850.00$26,258.71
Total dividends collected$957112100063.81M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RPFG vs PFE ($10,000, DRIP)

YearRPFG PortfolioRPFG Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$6,260,700$6,250,000.00$9,153$693.39+$6.25MRPFG
2$1,835,174,416$1,828,475,467.29$8,593$849.25+$1835.17MRPFG
3$252,418,700,426$250,455,063,800.57$8,336$1,066.78+$252418.69MRPFG
4$16,367,654,356,744$16,097,566,347,288.20$8,437$1,384.80+$16367654.35MRPFG
5$505,279,215,990,186$487,765,825,828,469.50$9,013$1,875.40+$505279215.98MRPFG
6$7,576,920,202,151,404$7,036,271,441,041,906.00$10,306$2,680.72+$7576920202.14MRPFG
7$57,412,205,565,343,256$49,304,900,949,041,250.00$12,820$4,101.38+$57412205565.33MRPFG
8$236,008,385,134,812,700$174,577,325,179,895,420.00$17,673$6,826.70+$236008385134.80MRPFG
9$587,878,163,749,896,600$335,349,191,655,647,000.00$27,543$12,591.86+$587878163749.87MRPFG
10$1,019,369,930,368,612,400$390,340,295,156,222,850.00$49,560$26,258.71+$1019369930368.56MRPFG

RPFG vs PFE: Complete Analysis 2026

RPFGStock

Rainier Pacific Financial Group Inc. operates as the holding company for Rainier Pacific Savings Bank, which provides various banking services. Its deposit products include checking accounts, money market deposit accounts, savings accounts, certificates of deposit, and individual retirement accounts. The company's lending products include one-to-four family, multifamily, and commercial real estate loans; real estate construction loans, such as residential construction loans, single family land acquisition and development loans, and lot inventory loans; and consumer installment loans, such as auto, boats, recreational, home equity, and personal loans, as well as unsecured personal lines of credit, home equity lines of credit, and credit cards. In addition, it provides automobile and homeowners' insurance, financial planning, and non-federally insured mutual fund and investment services. The company provides its services to consumers, small and medium-sized businesses, and professionals. As of June 30, 2009, it operated 14 branch offices in the Tacoma-Pierce County market and the City of Federal Way, Washington State. The company was founded in 1932 and is based in Tacoma, Washington.

Full RPFG Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this RPFG vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPFG vs SCHDRPFG vs JEPIRPFG vs ORPFG vs KORPFG vs MAINRPFG vs JNJRPFG vs MRKRPFG vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.